Table 3. Clinicopathological variables related to sL1CAM status in preoperative blood samples from women treated for endometrial cancer.
sL1CAM |
|||
---|---|---|---|
Variable | Low, n (%) | High, n (%) | P-value |
Age (years) | <0.001 | ||
<66 | 165 (89) | 20 (11) | |
⩾66 | 116 (62) | 71 (38) | |
Information available preoperatively | |||
Curettage histologya | <0.001 | ||
Low risk | 217 (80) | 54 (20) | |
High risk | 58 (62) | 36 (38) | |
PR curettage | 0.027 | ||
Positive | 160 (81) | 37 (20) | |
Negative | 37 (67) | 18 (33) | |
ER-α curettage | 0.023 | ||
Positive | 157 (81) | 37 (19) | |
Negative | 38 (67) | 19 (33) | |
Information available postoperatively | |||
FIGO-09 stage | <0.001 | ||
I–II | 252 (80) | 61 (20) | |
III–IV | 29 (49) | 30 (51) | |
Histologic type | <0.001 | ||
Endometrioid | 238 (80) | 61 (20) | |
Adenosquamous | 4 (100) | 0 (0) | |
Clear cell | 9 (75) | 3 (25) | |
Serous papillary | 18 (55) | 15 (45) | |
Carcinosarcoma | 10 (59) | 7 (41) | |
Undifferentiated/other | 2 (29) | 5 (71) | |
Histologic gradeb | 0.95 | ||
Grade 1/2 | 192 (80) | 48 (20) | |
Grade 3 | 47 (80) | 12 (20) | |
Metastatic nodes | 0.003 | ||
Negative | 225 (83) | 44 (17) | |
Positive | 22 (63) | 13 (37) | |
Myometrial infiltration | 0.027 | ||
<50% | 175 (80) | 42 (20) | |
⩾50% | 106 (71) | 44 (29) | |
Ploidy | 0.15 | ||
Diploid | 145 (78) | 42 (22) | |
Aneuploid | 31 (67) | 15 (33) |
Abbreviations: ER=oestrogen receptor; FIGO=Federation of Gynaecology and Obstetrics; PR=progesterone receptor; sL1CAM= soluble L1 cell adhesion molecule.
Missing information on curettage histology classification for 7 patients, PR status in curettage for 120 patients, ER-α status in curettage for 121 patients, grade for 4 patients, metastatic nodes for 68 patients, myometrial infiltration for 5 patients and ploidy for 139 patients.
Curettage histological risk classification, low risk (benign, hyperplasia or endometrioid grades 1–2) or high risk (non-endometrioid or endometrioid grade 3).
Only endometrioid.